“Innovating Textile Printing: Heat Transfer Film Market Insights”
Dive into the Heat Transfer Film Market, projected to reach $3866.9 million by 2030, with a notable 4.6% CAGR, driving advancements in textile printing.
Synopsis
The thermal transfer film is a dielectric material of the thermal transfer process.
The global Heat Transfer Film Market was valued at US$ 2812 million in 2023 and is anticipated to reach US$ 3866.9 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The major players in global Heat Transfer Film market include Decoral System, Stahls’ Inc, Guangdong Guanhao High-Tech, etc. The top 3 players occupy about 10% shares of the global market. Asia-Pacific is the main market, and occupies about 70% of the global market. Heat Transfer Plastic Film is the main type, with a share about 50%. Textile Industry is the main application, which holds a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Heat Transfer Film, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heat Transfer Film.
Report Scope
The Heat Transfer Film market size, estimations, and forecasts are provided in terms of output/shipments (K Sqm) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heat Transfer Film market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heat Transfer Film manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heat Transfer Film manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Heat Transfer Film by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Heat Transfer Film in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
At ‘The Market Reports’, we are a trusted market research firm dedicated to empowering businesses with valuable insights and data to drive their success. We offer a wide range of comprehensive market research reports to meet the unique needs of each client. From market analysis and competitive intelligence to consumer behaviour and trend forecasting, we provide the critical information necessary to make informed decisions and stay ahead of the competition. Our goal is to empower our clients with the knowledge they need to drive growth, make strategic investments, and seize new opportunities.
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Sensorineural Hearing Loss pipeline constitutes 15+ key companies continuously working towards developing 15+ Sensorineural Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Sensorineural Hearing Loss Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
“Sensorineural Hearing Loss Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sensorineural Hearing Loss Market.
Some of the key takeaways from the Sensorineural Hearing Loss Pipeline Report:
Companies across the globe are diligently working toward developing novel Sensorineural Hearing Loss treatment therapies with a considerable amount of success over the years.
Sensorineural Hearing Loss companies working in the treatment market are Acousia Therapeutics, Decibel Therapeutics, Suzhou Pharmaceutical Technology Co.,Ltd, AudioCure Pharma GmbH, Sensorion, and others, are developing therapies for the Sensorineural Hearing Loss treatment
Emerging Sensorineural Hearing Loss therapies in the different phases of clinical trials are- ACOU085, Cochlear Hair Cell Regeneration, HY01, AC102, SENS-401, and others are expected to have a significant impact on the Sensorineural Hearing Loss market in the coming years.
In January 2022, Sensorion reported that the Phase II AUDIBLE-S clinical trial investigating its drug candidate SENS-401 (Arazasetron) for the treatment of sudden sensorineural hearing loss (SSNHL) did not achieve its primary objective. The treatment did not demonstrate a significant improvement of 15 decibels (dB) in pure tone audiometry (PTA) within the affected ear compared to the placebo after four weeks of treatment, which was the primary endpoint.
Sensorineural Hearing Loss Overview
Sensorineural hearing loss (SNHL) occurs due to damage to inner ear structures or the auditory nerve. It accounts for over 90 percent of hearing impairment in adults. Typical causes of SNHL include prolonged exposure to loud noises, genetic predisposition, or the natural aging process.
Get a Free Sample PDF Report to know more about Sensorineural Hearing Loss Pipeline Therapeutic Assessment-
Sensorineural Hearing Loss Route of Administration
Sensorineural Hearing Loss pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
Intra-articular
Intraocular
Intrathecal
Intravenous
Ophthalmic
Oral
Parenteral
Subcutaneous
Topical
Transdermal
Sensorineural Hearing Loss Molecule Type
Sensorineural Hearing Loss Products have been categorized under various Molecule types, such as
Products have been categorized under various Molecule types such as
Oligonucleotide
Peptide
Small molecule
Sensorineural Hearing Loss Pipeline Therapeutics Assessment
Sensorineural Hearing Loss Assessment by Product Type
Sensorineural Hearing Loss By Stage and Product Type
Sensorineural Hearing Loss Assessment by Route of Administration
Sensorineural Hearing Loss By Stage and Route of Administration
Sensorineural Hearing Loss Assessment by Molecule Type
Sensorineural Hearing Loss by Stage and Molecule Type
DelveInsight’s Sensorineural Hearing Loss Report covers around 15+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration
Further Sensorineural Hearing Loss product details are provided in the report. Download the Sensorineural Hearing Loss pipeline report to learn more about the emerging Sensorineural Hearing Loss therapies
Some of the key companies in the Sensorineural Hearing Loss Therapeutics Market include:
Key companies developing therapies for Sensorineural Hearing Loss are – Sensorion, Fennec Pharmaceuticals, Sound Pharmaceuticals, Decibel Therapeutics, Akouos, and others.
Sensorineural Hearing Loss Pipeline Analysis:
The Sensorineural Hearing Loss pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the treatment of Sensorineural Hearing Loss with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Sensorineural Hearing Loss Treatment.
Sensorineural Hearing Loss key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Sensorineural Hearing Loss Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Sensorineural Hearing Loss market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Sensorineural Hearing Loss Pipeline Market Drivers
Rise in the Incidence of Sensorineural hearing loss, rising Awareness and Initiatives about Hearing loss are some of the important factors that are fueling the Sensorineural Hearing Loss Market.
Sensorineural Hearing Loss Pipeline Market Barriers
However, high Cost of treatment, presence of Substitute Products and other factors are creating obstacles in the Sensorineural Hearing Loss Market growth.
Scope of Sensorineural Hearing Loss Pipeline Drug Insight
Coverage: Global
Key Sensorineural Hearing Loss Companies: Acousia Therapeutics, Decibel Therapeutics, Suzhou Pharmaceutical Technology Co.,Ltd, AudioCure Pharma GmbH, Sensorion, and others
Key Sensorineural Hearing Loss Therapies: ACOU085, Cochlear Hair Cell Regeneration, HY01, AC102, SENS-401, and others
Sensorineural Hearing Loss Therapeutic Assessment: Sensorineural Hearing Loss current marketed and Sensorineural Hearing Loss emerging therapies
Sensorineural Hearing Loss Market Dynamics: Sensorineural Hearing Loss market drivers and Sensorineural Hearing Loss market barriers
16 . Sensorineural Hearing Loss Market Drivers and Barriers
17. Sensorineural Hearing Loss Future Perspectives and Conclusion
18. Sensorineural Hearing Loss Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact Company Name:DelveInsight Contact Person: Gaurav Bora Email:Send Email Phone: +14699457679 Address:304 S. Jones Blvd #2432 City: Albany State: New York Country: United States Website:https://www.delveinsight.com/
“Seasonal Influenza Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Seasonal Influenza, historical and forecasted epidemiology as well as the Seasonal Influenza market trends in the 7MM.
DelveInsight’s “Seasonal Influenza Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Seasonal Influenza, historical and forecasted epidemiology as well as the Seasonal Influenza market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Seasonal Influenza market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Seasonal Influenza Market Forecast
Some of the key facts of the Seasonal Influenza Market Report:
The Seasonal Influenza market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
Only 49.2% of people aged 6 months and older who participated in the National Health Interview Survey (NHIS) reported having had a seasonal influenza vaccination for the flu season 2017–2018. Additionally, the NHIS indicated that their goal is to have 70% of people immunized against seasonal flu by the year 2030
Acute pneumonia is a diagnosis made in about 30–40% of hospitalized individuals with laboratory-confirmed influenza. These individuals who get pneumonia are more likely to be less than five years old, older than 65, Caucasian, nursing home residents, have a history of smoking and chronic lung or heart illness, and be immunocompromised
Key Seasonal Influenza Companies: Cidara, Moderna, SAB Therapeutics, Sinovac Biotech, Novartis, and others
The Seasonal Influenza epidemiology based on type-specific cases analyzed that More patients of Influenza type-A were found compared to type-B
The Seasonal Influenza market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Seasonal Influenza pipeline products will significantly revolutionize the Seasonal Influenza market dynamics.
Seasonal Influenza Overview
The World Health Organization (WHO) describes seasonal influenza as an acute respiratory infection brought on by influenza viruses that are spread throughout the globe.
Get a Free sample for the Seasonal Influenza Market Report
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Seasonal Influenza Epidemiology Segmentation:
The Seasonal Influenza market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Seasonal Influenza
Prevalent Cases of Seasonal Influenza by severity
Gender-specific Prevalence of Seasonal Influenza
Diagnosed Cases of Episodic and Chronic Seasonal Influenza
Seasonal Influenza Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Seasonal Influenza market or expected to get launched during the study period. The analysis covers Seasonal Influenza market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Seasonal Influenza Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
14. Seasonal Influenza Market Access and Reimbursement of Therapies
15. Seasonal Influenza Market Drivers
16. Seasonal Influenza Market Barriers
17. Seasonal Influenza Appendix
18. Seasonal Influenza Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact Company Name:DelveInsight Contact Person: Gaurav Bora Email:Send Email Phone: +14699457679 Address:304 S. Jones Blvd #2432 City: Las Vegas State: NV Country: United States Website:https://www.delveinsight.com/
The Vascular Ehlers-Danlos Syndrome market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Vascular Ehlers-Danlos Syndrome pipeline products will significantly revolutionize the Vascular Ehlers-Danlos Syndrome market dynamics.
DelveInsight’s “Vascular Ehlers-Danlos Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Vascular Ehlers-Danlos Syndrome, historical and forecasted epidemiology as well as the Vascular Ehlers-Danlos Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Vascular Ehlers-Danlos Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Vascular Ehlers-Danlos Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Vascular Ehlers-Danlos Syndrome Market Insights
Vascular Ehlers-Danlos Syndrome Overview
Vascular Ehlers-Danlos Syndrome, or VEDS, is a genetic disorder that affects the body’s connective tissue. Connective tissue holds all the body’s cells, organs, and tissue together. It also plays an important role in helping the body grow and develop properly.
Some of the key facts of the Vascular Ehlers-Danlos Syndrome Market Report:
The Vascular Ehlers-Danlos Syndrome market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
According to the VEDS Movement (n.d.), the exact number of affected people with Vascular Ehlers-Danlos Syndrome is not known
According to a news article published by Ehlers-Danlos Support United Kingdom, the prevalence of EDS is generally quoted as 1 in 5000. Seventy percent of the individuals with EDS or JHS are female and thirty percent are male.
Key Vascular Ehlers-Danlos Syndrome Therapies: AR101 (enzastaurin), Edsivo, and others
The Vascular Ehlers-Danlos Syndrome epidemiology based on gender analyzed that among all hospitalized and GP practice EDS patients, approximately 70% were females
Get a Free sample for the Vascular Ehlers-Danlos Syndrome Market Report-
Key benefits of the Vascular Ehlers-Danlos Syndrome Market report:
Vascular Ehlers-Danlos Syndrome market report covers a descriptive overview and comprehensive insight of the Vascular Ehlers-Danlos Syndrome Epidemiology and Vascular Ehlers-Danlos Syndrome market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Vascular Ehlers-Danlos Syndrome market report provides insights on the current and emerging therapies.
Vascular Ehlers-Danlos Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Vascular Ehlers-Danlos Syndrome market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Vascular Ehlers-Danlos Syndrome market.
Vascular Ehlers-Danlos Syndrome Market
The dynamics of the Vascular Ehlers-Danlos Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“The emerging pipeline for the treatment of Vascular Ehlers-Danlos Syndrome (vEDS) has two therapies AR101 (enzastaurin) and Edsivo. A very few candidates are being investigated by pharmaceuticals companies in this disease area”
Vascular Ehlers-Danlos Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Vascular Ehlers-Danlos Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vascular Ehlers-Danlos Syndrome market or expected to get launched during the study period. The analysis covers Vascular Ehlers-Danlos Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Vascular Ehlers-Danlos Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact Company Name:DelveInsight Contact Person: Gaurav Bora Email:Send Email Phone: +14699457679 Address:304 S. Jones Blvd #2432 City: Las Vegas State: NV Country: United States Website:https://www.delveinsight.com/
Steed Rollins, a distinguished Realtor in Durham, NC, is significantly contributing to the advancement of the real estate profession as a board member of the Durham Regional Association of Realtors. His involvement underscores his commitment to elevating the standards of service and expertise in the industry.
Since his foray into real estate in 2014, Rollins has been a driving force in the Durham market. “Serving on the board is an opportunity to give back to the community and shape our industry’s future,” Rollins remarks. This leadership role allows him to impact positively the professional development of Realtors in Durham, NC.
Rollins’ contribution extends beyond his board duties. His approach as a top real estate agent in Durham, NC is marked by an unwavering commitment to his clients. He prides himself on understanding each client’s unique needs, ensuring that every transaction aligns with their specific goals.
As a real estate selling agent in Durham, NC, Rollins applies his extensive market knowledge and negotiation skills to secure the best outcomes for his clients. “My mission is to ensure that every sale is handled with the utmost professionalism and care,” he states.
Rollins encourages prospective buyers and sellers to seek his expertise. His blend of market savvy, client-centric service, and leadership within the industry positions him as a top Realtor agent in Durham, NC.
For those looking to buy or sell property in Durham, NC, Steed Rollins is a name synonymous with reliability, expertise, and personalized service. For more information, visit Steed Rollins’ website and discover the advantages of working with a leading Realtor in Durham, NC. Learn more at the website. Visit http://steedrollins.com/.
In the scenic and vibrant community of Greenbrae, CA, Jenn Pfeiffer stands out as an emblem of excellence in the real estate industry. With nearly 25 years of dedicated service, this esteemed Realtor has made a significant impact on the lives of her clients, assisting both sellers and buyers in the area, with unmatched expertise and commitment. Her journey, enriched by personal and professional experiences, underscores her reputation as a premier Realtor in Greenbrae, CA.
“Real estate for me is about forging lasting relationships and guiding clients through one of their most crucial life decisions with integrity and profound market insight,” Pfeiffer shares. Her client-first approach and ethical advisory have solidified her position as a leading Realtor agent in Greenbrae, CA, celebrated for her strategic savvy and deep-rooted understanding of the market dynamics. Recognition as the best agent in San Francisco in 2021 by SF Weekly is a testament to her dedication and excellence in the field.
Beyond her remarkable sales achievements, Pfeiffer has significantly contributed to the real estate community, serving as a managing broker, the Class B Director of BAREIS, and a member of the Board of Directors for BAREIS. This role serves the real estate industry across nine counties, highlighting her influence and dedication to elevating industry standards. Additionally, her involvement in the Marin Realtors Grievance Committee showcases her commitment to fairness and integrity in real estate practices.
Jenn Pfeiffer has recently been honored by The Marin Independent’s Readers Choice Awards as Best Realtor for Marin County, receiving an honorable mention. This prestigious recognition further solidifies her reputation, showcasing her as a leading real estate agent renowned for her exceptional service and expertise in the region.
As Pfeiffer continues to redefine the real estate experience for her clients, her approach remains unwaveringly focused on personalized service. “Ensuring that each client feels fully supported and confident in their real estate decisions is my utmost priority,” Pfeiffer asserts, emphasizing her goal of leveraging her extensive experience for their benefit.
Celebrating nearly a quarter-century of unparalleled service, Jenn Pfeiffer is not just a real estate selling agent in Greenbrae, CA; she is a trusted advisor and partner in your real estate journey. Visit her website at http://www.jennpfeiffer.com/ to discover how her seasoned expertise and dedicated approach can guide you through the Greenbrae real estate market with confidence and success.
In a world where technology and real estate intersect, Ninah Hunter stands out as a pioneering Realtor® in Ridgway, CO. With a career spanning over two decades, Hunter has consistently embraced the internet and cutting-edge technologies to enhance her real estate services, setting her apart as a visionary real estate agent in Ridgway, CO.
“Integrating technology into my real estate practice was a natural progression for me,” explained Hunter. “It’s about offering flexibility, efficiency, and accessibility to my clients, no matter where they are or what their schedules might look like.”
Hunter’s tech-savvy approach includes everything from virtual property tours to digital contracts, enabling her to stay connected with clients across the globe. Her expertise in online marketing and social media has also been instrumental in showcasing properties to a wider audience, making her a top choice for those selling homes in Ridgway, CO.
“As we move forward, my focus remains on leveraging technology to enhance the client experience, while still preserving the personal touch that is so crucial in real estate transactions,” Hunter remarked.
For individuals looking for one of the best, forward-thinking Realtor® agents in Ridgway, CO, Ninah Hunter provides a unique blend of traditional real estate acumen and modern technological insight. Discover how Hunter can assist with your real estate needs by visiting Hunter Realty’s website at https://www.HunterRealtyCO.com.
Apple Valley, MN – In an extraordinary display of real estate excellence, Jeff Scislow – a well-known real estate agent in Apple Valley, MN, has been honored with two prestigious Reader’s Choice Awards in 2024. Recognized for his significant contributions to the Apple Valley real estate scene, Scislow has earned accolades for both his individual performance and his leadership at RE/MAX Results. These awards celebrate his dedication to providing outstanding service and achieving exceptional results for his clients.
Jeff Scislow’s commitment to excellence extends beyond these awards, as evidenced by his recognition in Minnesota Monthly as one of the best Real Estate Professionals for 2024. This honor places him among the elite in his field, showcasing his comprehensive expertise and dedication to his clients’ success.
Reflecting on his achievements, Jeff Scislow shared, “These awards are a testament to our team’s hard work and the trust our clients place in us. We are committed to continuing our tradition of excellence and setting even higher standards for ourselves in the future.” His words underscore the passion and dedication that have made him a leading figure amongst Realtor agents in Apple Valley, MN.
Under Scislow’s guidance, his team at RE/MAX Results has become synonymous with success and reliability. Their client-focused approach and deep market knowledge have enabled them to deliver unparalleled service and achieve outstanding results, solidifying their reputation as top Realtors in Apple Valley, MN.
For individuals looking to buy or sell property in Apple Valley, Jeff Scislow and his team offer a level of service and expertise that is unmatched. With their award-winning approach and commitment to client satisfaction, they are the ideal partners for all your real estate needs. Visit https://www.southmetrohouses.com/ to learn more about how they can assist you in achieving your real estate goals.
“Amalyn Origin Collection in Bethesda, Maryland (Photo credit: Studio Trejo)”
IRVINE, Calif. – KTGY, a Great Places to Work certified design firm focused on architecture, branding, interiors and planning, announced today that it earned 22 prestigious awards, including four Platinum awards, three Gold awards and 15 Silver awards at the recent National Association of Home Builders’ (NAHB) awards events held during the International Builders’ Show in Las Vegas, Nevada: the Best in American Living™ Awards (BALA) and The Nationals℠. The awards recognize KTGY’s wide range of capabilities, excellence and innovation in the design and planning of attached and detached single-family and multifamily residential and mixed-use communities.
BEST IN AMERICAN LIVING AWARDS
Now in its 40th year, NAHB’s Best in American Living Awards (BALA) is the building industry’s premier residential design awards program. BALA recognizes outstanding achievement by builders and design professionals in all sectors of the residential housing industry including single-family production, custom, multifamily, affordable, remodeling, community and interiors. BALA is built on the principle that all great homes start with great design, no matter cost or size. The winners were announced at the Best in American Living Awards virtual award ceremony on February 28.
KTGY’s Platinum BALA Awards:
Attached Homes/Townhomes, Built for Sale Amalyn Origin Collection in Bethesda, Maryland Architect/Designer: KTGY Developer: Tri Pointe Homes
Detached Home up to 2,001 – 2,500 sq. ft., Built for Sale L’Aube at Solis Park – Plan 1 in Irvine, California Architect/Designer: KTGY Builder/Developer: Trumark Homes Interior Designer: CDC Designs
On-the-Boards Multifamily Project
Atwell on Spring in Silver Spring, Maryland Architect/Designer: KTGY Builders/Developers: Bozzuto | Stonebridge Carrass Landscape Architect/Designer: MPFP Interior Designer: Grizform Design
Affordable, Multifamily Canyon Flats & Reilly Station in Fremont, California Architect/Designer: KTGY Builder/Developer: Eden Housing Landscape Architect/Designer: JETT Landscape Architecture + Design
KTGY’s Gold BALA Awards:
On-the-Boards Community Blackwood Groves in Bozeman, Montana Architect/Designer/Site Planner: KTGY Builder/Developer: Bridger Land Group Land Planner: Design Workshop
Detached Home up to 2,000 sq. ft., Built for Sale L’Aube at Solis Park – Plan 2 in Irvine, California Architect/Designer: KTGY Builder/Developer: Trumark Homes Interior Designer: CDC Designs
Multifamily, Development 4 – 7 Stories, For Rent NINE88 in South San Francisco, California Architect/Designer: KTGY Builder: SBI Builders Developer: SummerHill Apartment Communities Interior Designer: Ryan Young Interiors
KTGY’s Silver BALA Awards:
Single-Family, Detached or Attached, For Rent BB Living Harvest in Argyle, Texas Architect/Designer: KTGY Builder: BB Living Developer: Hillwood Landscape Architect/Designer: TBG
Detached Home Over 4,500 sq. ft., Built for Sale SkyVu at McDonald Highlands in Henderson, Nevada Architect/Designer: KTGY Builder/Developer/Land Planner: Christopher Homes Landscape Architect/Designer: Nuvis Interior Designer/Merchandiser: Design Tec Inc.
Multifamily, Development 4 – 7 Stories, For Rent Novel Edgehill in Nashville, Tennessee Architect/Designer: KTGY Builders/Developers: Crescent Communities | Pearl Street Partners Landscape Architect/Designer: Hawkins Partners Inc. Interior Designer/Merchandiser: CID Design Group
THE NATIONALS AWARDS The National Association of Home Builders (NAHB) honored outstanding residential real estate sales, marketing and design, 55+ housing projects, individual achievement and global excellence at the National Sales and Marketing Awards gala (known as “The Nationals℠”) on February 27. A diverse panel of industry professionals selected the award winners from almost 1,200 entries.
KTGY’s Silver Nationals Awards:
Multifamily Community of the Year – 4 Stories and Above, Best Community Amenity – Structure, and Best Sales/Leasing Center NINE88 in South San Francisco, California Design: KTGY By: SummerHill Apartment Communities
Multifamily Community of the Year – 4 Stories and Above, and Best Multifamily Community MV in Mountain View, California Design: KTGY By: SummerHill Apartment Communities
Multifamily Community of the Year – 4 Stories and Above, and Best Community Amenity – Structure Prado in Santa Clara, California Design: KTGY By: SummerHill Apartment Communities
Best Multifamily Model Home Amalyn Origin Collection in Bethesda, Maryland Design: KTGY By: Tri Pointe Homes Best Single-Family Detached Model Home Under 2,000 Sq. Ft. L’Aube at Solis Park – Plan 1 in Irvine, California Design: KTGY By: Trumark Homes
Best Single-Family Detached Model Home 2,501 To 3,000 Sq. Ft. Sterling Grove – The Rutherford Plan in Surprise, Arizona Design: KTGY By: Toll Brothers
Best Single-Family Detached Home Over 4,000 Sq. Ft. SkyVu at McDonald Highlands – Peninsula in Henderson, Nevada Design: KTGY By: Christopher Homes
Best Detached Home for 55+ Buyer Regency at Desert Color – Cliff Rose Collection – Verde in St. George, Utah Design: KTGY By: Toll Brothers
Additionally, three designs by KTGY have earned finalist honors in NAHB’s Multifamily Pillars of the Industry Awards program: Best Affordable Apartment Community (Up to 100 Units) for Casa Paloma in Midway City, California; Best 55+ Multifamily Community for Entwine in Washington, D.C.; and Best Low-Rise Apartment Community (Non-Garden, Five Stories or Less) for Halcyon House in Costa Mesa, California. The winners will be announced during a virtual awards presentation on March 21.
About KTGY
Founded in 1991, KTGY is an award-winning design firm partnering with clients to deliver world-class architecture, branding, interiors and planning. Our firm and our work are guided by a continuous focus on innovation, creativity, collaboration, and a deep commitment we have towards making a positive impact on people and their communities. We use storytelling and design to envision and enliven spaces that transform people’s experiences. Visit www.ktgy.com.
Media Contact Company Name:KTGY Contact Person: Brianne Wagner, Director, Demand Marketing Email:Send Email Phone: 18884565849 Address:17911 Von Karman Avenue Suite 200 City: Irvine State: CA Country: United States Website:http://ktgy.com
Agrify Corp (NASDAQ: AGFY) stock shifted into rally mode last week, soaring over 63% from its intra-week low of $0.46 to $0.75 before giving back some to profit-taking and closing the trading week at $0.60. Even with profit-taking, the increase at the close represented an impressive tally. But here’s the better news for those investors who missed the initial move- it could be the precursor to higher highs, especially on the heels of news indicating AGFY is growing revenues faster than many expected. Better still, those revenues result from a company shifting from hyper-growth speed to warp.
That’s not an exaggeration. And considering volume was 10X its normal pace, with over 22 million shares exchanging hands last Thursday, investors apparently do more than agree, they want onboard. That’s understandable. Despite the jump in value, AGFY trading under a dollar still exposes a significant disconnect between AGFY assets, inherent potential, and its share price. That gap is based just on the knowns. It’s also important to include forward-looking projections when appraising Agrify, accounting for its intentions to grow into a much larger company in 2024.
That optimism is warranted, justified by tangibles, including that despite its microcap size, Agrify is a respected and leading provider of innovative cultivation and extraction solutions for a booming industry. Additionally, AGFY is one of the few companies to combine data, science, and technology to not only support its strengthening market position but to also and enhance it and keep them at the forefront of a sector revolution regarding hydrocarbon extraction technology.
The Thursday surge appeared to be in response to the company signing a multi-year cultivation and extraction deal with HarvestWorks Farm, New Jersey, a licensed New Jersey operator. The deal is comprehensive and includes a $3.4 million cultivation and extraction order for 156 of Agrify’s Vertical Farming Units, a complete Turnkey Pure Pressure Solventless extraction Lab Package, a 2-year Service Support and Production Success Fee agreement at $350 per pound, and a five-year SaaS Fee Agreement worth $1 million.
Here’s something to consider- this deal can usher in many more like it. That’s because HarvestWorks Farm is a well-known company and one of the first operators licensed for plant cultivation and manufacturing in the state. In other words, being chosen by and serving the best excellent on the business resume’. And with New York and other states around the Jersey borders virtually decriminalizing use, competition in the space will be fierce. Similar to most competitive industries, only the strong will survive. And since Agrify fortifies client strengths, this under-a-dollar company is well-positioned to exploit a potentially massive national and regional opportunity.
Also, keep in mind that from a fundamentals perspective, AGFY is doing the work to make sure business earned can and will fall faster to its bottom line. A recent update from the company provided bullish guidance for 2024, told investors to expect significantly better bottom line results, and hinted at gross profit to increase by 105% to $1.9 million in Q4. That’s not all. Investors were told to expect AGFY to post the lowest cash burn in its history, which will put them on course to reach cash flow breakeven by the second half of this year. The Q4 report is expected to be released before the end of March. Confirming guidance and providing another round of bullish commentary could help fuel the next leg higher in an already impressive rally.
Of course, abilities matter. After all, they are the value drivers that make small companies larger. Agrify has plenty. And clients appreciate the value provided.
A Products Portfolio Presenting A Win-Win Proposition
Particularly, Agrify’s proprietary micro-environment-controlled Vertical Farming Units (VFUs) enable cultivators to produce the highest quality products with unmatched consistency, yield, and ROI. Better yet, clients can do so at scale when using AGFY’s comprehensive extraction product line, including hydrocarbon, ethanol, solventless extraction, post-processing, and lab equipment. This empowers producers to maximize the quantity and quality of extract required for premium concentrates. Simply said, Agrify clients can do less work to make more money.
Many are. Last month, Agrify announced the successful installation of a PX-30 Hydrocarbon Extraction System at Lume CC’s Michigan facility. That implementation facilitates a win-win proposition. For Agrify, installing the PX-30 Hydrocarbon Extraction System is a milestone in revenue generation and product validation. That validation may be the more valuable long-term consideration, noting the endorsement of the most extensive system in its PX-Extraction series could lead to additional sales. Considering the PX-30 represents cutting-edge design advancement in hydrocarbon extraction technology to enhance efficiency and precision in the extraction process, that’s likely. Especially in a sector where brand quality can be an unrivaled competitive advantage.
Remember, for companies to stay competitive in a red-hot industry, quality control, consistency, and scale are vital. There are few second chances in a saturated market and more likely than not no third chances. In other words, the best defense against competitive poachers is having a better offense, in this case, better products. That reason is bringing Agrify onto more client and investor radars. Deservedly so. Remember, validation supports growth. And by proving its abilities to deliver and integrate state-of-the-art solutions to the CBD and hemp industries across the country, Agrify is building on an already solid reputation.
Repeat Orders Are Validation
That’s driving repeat business, evidenced by its latest sale to Lume, which has been operating with Agrify’s XMU Hydrocarbon Extraction System. As its business grew and the operation required additional speed and throughput, it wasted no time turning to Agrify for solutions that provide immediate and accretive impact. As noted, they purchased the PX-30 system through Agrify’s subsidiary, Precision Extraction Solutions, intending to elevate its extraction capabilities and meet the increasing demand for premium extracts in the CBD and hemp markets. Reasons support Lume’s decision.
Key features of the PX-30 hydrocarbon extraction system include:
High Extraction Efficiency: The PX-30 ensures optimal extraction yields, maximizing the production of high-quality extracts of up to 240+ lbs. per 8-hour shift.
Operational Design: Created with the operator in mind, the PX-30 offers ultra-low temperature operation with fast recovery times, with or without a compressor. All functions and features are easily accessible in a linear process flow with conveniently located controls and ergonomics designed for the operator.
Safety/Compliance: Agrify prioritizes safety, and the PX-30 is built with state-of-the-art safety features to comply with 3A sanitary and cGMP standards.
Those differences become client advantages. And combining the two to generate sales, the perceived valuation gap between assets, revenues, and share price could close quickly. Driving that intention is that Agrify is leveraging industry-best solutions that keep them well-positioned to capitalize on revenue-generating opportunities from equipment sales needed in today’s ancillary extraction market. Other news attracted investor interest.
Also in February, Agrify announced signing a Turnkey Ethanol Extraction and Lab Equipment Package deal with Denver Cole Labs, a conditionally licensed New Jersey operator. It’s a substantial purchase. Precision Extraction’s Turnkey Ethanol Extraction and Lab Equipment Package comprises a C-15 Centrifuge Ethanol Extractor, Solvent Recovery System, Decarboxylation Package, Short Path Distillation Kit, and Expert On-Site training. Denver Cole has also elected Precision Extraction’s C1D1 Extraction Booth to safely manufacture products in their lab. In addition, Agrify’s EliteLab distillation control and tracking software will help manage and optimize the day-to-day operation of the G3X-R short path system. Order cost is expected to reach upwards of $500,000 to start. They could grow appreciably higher through add-ons or by Agrify again showing proof of concept to other potential sector clients.
Notably, the deal with Denver Cole Labs does more than expand Agrify’s market presence; it also enhances its pedigree as a premium extraction services equipment provider in New Jersey. Moreover, it adds to the growing partnerships in the Northeast and across the country, a solid testimony to operators’ trust in Agrify’s team and technologies in the most competitive markets. This newest deployment will allow Denver Cole to produce high-quality ethanol extracts at scale, benefitted by repeatability and ensuring consistent products every run. Of interest, Agrify’s technical and compliance experts were instrumental in selecting the equipment package under New Jersey regulations to meet the customer’s goals. Navigating those compliance issues is an Agrify service that must be fully appreciated, especially as a powerful resource for building additional long-term client relationships across the United States. The news flow in February didn’t end with those announcements.
Additional February Deals Contribute To The Bullish Thesis
Last month, Agrify announced signing a term sheet with PDS Ventures, LLC, a licensed Michigan operator, providing them a multi-year end-to-end managed extraction services agreement. This Managed Services agreement adds a new revenue stream, serving as a first-of-its-kind program where Agrify leases turnkey extraction and post-processing lab equipment to qualified operators. The company will also provide a full-time, on-site, hands-on customer success specialist to guide and manage extraction-related operations for the customer. The goal is to leverage the value inherent to these Managed Services to significantly increase the average lifetime value of our customers. But it’s also designed to make money. Quickly.
The multi-year Managed Service contract facilitates Agrify to collect monthly production success fees based on the finished product produced, including a monthly management fee during the contract term. Its deal with PDS Ventures could earn Agrify up to $2 million throughout the lifetime of this multi-year managed service contract. That’s just one agreement. This services model could explode in popularity, intensifying Agrify’s sweet spot of opportunity through 2024. With client endorsements referring to this Managed Services product as a business “game changer,” exploiting that potential can be potentially lucrative for the company in coming quarters.
There’s much to like about this fast-growing company. And the good news is that AGFY is eager to tell its story, providing investors with plenty of ammunition to make an informed investment decision. Couple expected catalysts with a potentially record-setting financial performance in Q4, the bullish action ahead of updates is understandable. After all, they’ve talked about value-creating events, including new revenue streams, increasing deal-making momentum, best ever operating performance, and showing it can compete with sector large caps. Thus, while the bullish case for any stock is usually speculative, there is a way to mitigate risk. Find companies that provide evidence-based contributions to formulate the appraisal. Agrify Corp. does that. And because of that, the AGFY share price may do more than follow an optimistic lead; it might precede it.
Disclaimers and Disclosures: This Disclaimer and Disclosure statement is a permanent part of this content. Any reproduction of this content in part or whole that does not include the Disclaimer and Disclosure statement is unauthorized and strictly prohibited. Hawk Point Media Group, Llc. (HPM) is responsible for the production and distribution of this content. Hawk Point Media Group, Llc. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by Hawk Point Media Group, Llc. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors do NOT buy and sell securities before and after any particular article, report and publication. HPM holds ZERO shares and has never owned stock in Agrify Corp. In no event shall Hawk Point Media Group, Llc. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Hawk Point Media Group, Llc., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Hawk Point Media Group, Llc. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. This advertisement is being disseminated for a period of one week beginning on 03/02/24 and ending on 03/08/24. HPM LLC. owners, officers, principals, affiliates, contributors, and/or related parties do not own, intend to own, sell, or intend to sell Agrify Corp. stock. However, it is prudent to expect that those hiring Hawk Point Media, Llc, including that company’s owners, employees, and affiliates may sell some or even all of the Agrify Corp. shares that they own, if any, during and/or after this engagement period. If successful, this advertisement will increase investor and market awareness of Agrify Corp. and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. For some content, HPM, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. Hawk Point Media Group, LLC. has been compensated five-thousand-dollars cash via wire transfer from One Eyed Jack Enterprises, Inc. to produce and syndicate content for Agrify Corp. for a period of one week beginning on 03/02/24 and ending on 03/08/24. This compensation is a major conflict of interest in our ability to be unbiased regarding our alerts. Therefore, this communication should be viewed as a commercial advertisement only. Any non- compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. As part of all content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website. Contributors reserve the right, but are not obligated to, submit articles for fact-checking prior to publication. Contributors are under no obligation to accept revisions when not factually supported. Furthermore, because contributors are compensated, readers and viewers of this content should always assume that content provided shows only the positive side of companies, and rarely, if ever, highlights the risks associated with investment. Thus, readers and viewers should accept the content as an advertorial that highlights only the best features of a company. Never take opinion, articles presented, or content provided as a sole reason to invest in any featured company. Investors must always perform their own due diligence prior to investing in any publicly traded company and understand the risks involved, including losing their entire investment.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
Media Contact Company Name: Hawk Point Media Contact Person: Editorial Dept. Email: info@hawkpointmedia.com Country: United States Website:https://hawkpointmedia.com/
